A strong dose of reality: Households waste 70% medicines, shows survey

Even as the Ministry of Consumer Affairs is working on a proposal to ensure consumers buy only the quantity of medicines prescribed/desired and not the entire blister pack, a recent survey reveals otherwise. A survey conducted on over 33,000 respondents by LocalCircles says people throw away anything between 10 per cent and 70 per cent of the medicines bought/prescribed.

It shows 36 per cent of respondents discard up to 10 per cent of the medicines purchased; 27 per cent end up throwing out up to 10-30 per cent; 6 per cent dispose of 30-50 per cent of the medicines unused; and about 6 per cent scrap anything between 50 per cent and 70 per cent of the medicines acquired.
For syrups and eye drops, the full pack is sold, he adds, saying pharmacists mention the expiry date on a sticker when they dispense a partial pack to a customer.

Singhal says on average about 1.5 per cent of the overall medicines sold in the country are wasted as they expire and are sent back to pharma companies.
The Indian pharmaceutical (pharma) market is estimated to be about Rs 1.8 trillion. About Rs 270 crore worth of medicines are wasted once they are past their shelf life.

“Of this, 20-30 per cent are wasted at the pharmacy end as these are cut blister packs of medicines which a pharmacist cannot return to companies,” says Singhal. Most of this wastage is at the wholesaler end, he adds.
If the consumer affairs ministry mandates dispensing only the required quantity, it will be a welcome step, he says, adding pharmacies are already adhering to this practice.

According to reports, the consumer affairs ministry is considering issuing an advisory to the pharma sector to stop pharmacists from compelling consumers to buy the full blister pack when the quantity needed is much less.
  • Related Posts

    • Pharma
    • April 28, 2025
    • 97 views
    Gujrat leads pharma sector with record 183 new plants

    Ahmedabad:  Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25,…

    • Pharma
    • April 28, 2025
    • 107 views
    Doctor not liable for prescribing costly drug: HC

    Cuttack:  Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gujrat leads pharma sector with record 183 new plants

    Gujrat leads pharma sector with record 183 new plants

    Doctor not liable for prescribing costly drug: HC

    Doctor not liable for prescribing costly drug: HC

    878 Tramadol capsules being smuggled in Scorpio seized, three arrested

    878 Tramadol capsules being smuggled in Scorpio seized, three arrested

    Doctor not criminally liable for prescribing costly drug: Orissa High Court

    Doctor not criminally liable for prescribing costly drug: Orissa High Court

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion